Purpose of Treatment
Alesis OSA1 is a photobiomodulation (light therapy) protocol intended to reduce the severity of Obstructive Sleep Apnea (OSA) by delivering calibrated light energy to the tissues of the upper airway. The goal is reduction of the Apnea-Hypopnea Index (AHI) and improvement in sleep quality.
Treatment Protocol
The treatment consists of six sessions of approximately 12 minutes each, delivered twice per week over three weeks. The patient remains fully clothed during each session. A specialized light-emitting device is positioned near the patient’s neck and upper airway.
Expected Experience
Most patients report no sensation, discomfort, or pain during treatment. There is no anesthesia, injection, or incision involved. Patients may resume all normal activities immediately after each session. There is no known downtime or recovery period.
Contraindications
I confirm that I have reviewed the contraindications listed on this page and, to the best of my knowledge, none apply to me, or I have consulted with my physician regarding any applicable conditions. Contraindications include but are not limited to:
- Active cancer or malignancy in the treatment area
- Pregnancy or suspected pregnancy
- Active infection, open wounds, or lesions in the treatment area
- Photosensitizing medications without physician clearance
- Implanted electronic devices near the treatment field
- Known hypersensitivity to light therapy
- Uncontrolled thyroid disease
- Severe coagulopathy or active anticoagulant therapy without clearance
Potential Risks and Adverse Outcomes
While Alesis OSA1 has been designed for safety and tolerability, all medical treatments carry some level of risk. Potential risks include, but may not be limited to:
- Mild, transient skin warmth or redness at the treatment site (rare)
- Temporary discomfort in patients with pre-existing sensitivity to light (rare)
- Treatment may not achieve the desired reduction in AHI for all patients
- Rare or unanticipated adverse outcomes not yet identified in available clinical data
No Guarantee of Results
While clinical outcomes have been favorable, Alesis LLC does not guarantee a specific reduction in AHI or elimination of sleep apnea symptoms. Individual results may vary based on anatomical, physiological, and other patient-specific factors.
Voluntary Participation
My participation in Alesis OSA1 treatment is entirely voluntary. I understand that I may withdraw consent at any time prior to or during the treatment course. Refund policies will be discussed with an Alesis representative at the time of enrollment.
Data and Privacy
Information collected during enrollment and treatment will be maintained confidentially in Alesis LLC’s secure clinical registry and used solely for the purpose of managing my care and tracking clinical outcomes. This information will not be sold or shared with third parties without my explicit consent, except as required by law.
